Nkrumah-Elie, global director for external research at ChromaDex, was honored for her commitment to advancing science, diversity, and female leadership.
The cannabinoid was found to improve sleep quality with no side effects in 1,000 people, at levels more significant than standard-dose melatonin supplements.
The study conducted by MDbio in partnership with Radicle Science found improvements in measure of sleep, stress, and anxiety in a population of 620 adults.
The study on CBD, and combinations containing CBD and other rare cannabinoids was history’s largest IRB-approved clinical trial on cannabis extracts to date.
Over 1,600 people with pain were randomized to take one of six cannabinoid formulations containing CBD and some combination of rare cannabinoids from OBX.